These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22492655)

  • 1. Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics.
    Miyagi SJ; Milne AM; Coughtrie MW; Collier AC
    Drug Metab Dispos; 2012 Jul; 40(7):1321-7. PubMed ID: 22492655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric development of glucuronidation: the ontogeny of hepatic UGT1A4.
    Miyagi SJ; Collier AC
    Drug Metab Dispos; 2007 Sep; 35(9):1587-92. PubMed ID: 17556526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Ontogeny of Hepatic UDP-Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes.
    Badée J; Qiu N; Collier AC; Takahashi RH; Forrest WF; Parrott N; Schmidt S; Fowler S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S42-S55. PubMed ID: 31502688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9--potent inhibition by niflumic acid.
    Mano Y; Usui T; Kamimura H
    Biopharm Drug Dispos; 2006 Jan; 27(1):1-6. PubMed ID: 16278927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver.
    Miyagi SJ; Collier AC
    Drug Metab Dispos; 2011 May; 39(5):912-9. PubMed ID: 21266593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
    Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.
    Lee H; Heo JK; Lee GH; Park SY; Jang SN; Kim HJ; Kwon MJ; Song IS; Liu KH
    Drug Metab Dispos; 2019 Dec; 47(12):1372-1379. PubMed ID: 31578207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver.
    Girard H; Court MH; Bernard O; Fortier LC; Villeneuve L; Hao Q; Greenblatt DJ; von Moltke LL; Perussed L; Guillemette C
    Pharmacogenetics; 2004 Aug; 14(8):501-15. PubMed ID: 15284532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.
    Yu ML; Yang Y; Wang CM; Zhang MM; Bai MC; Guo YL
    Pharmazie; 2013 Jun; 68(6):449-52. PubMed ID: 23875253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental aspects of human hepatic drug glucuronidation in young children and adults.
    Strassburg CP; Strassburg A; Kneip S; Barut A; Tukey RH; Rodeck B; Manns MP
    Gut; 2002 Feb; 50(2):259-65. PubMed ID: 11788570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9.
    Mukai M; Tanaka S; Yamamoto K; Murata M; Okada K; Isobe T; Shigeyama M; Hichiya H; Hanioka N
    Pharmazie; 2014 Nov; 69(11):829-32. PubMed ID: 25985579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
    Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
    Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the glucuronidation of 2-(4-chlorophenyl)- 5-(2-furyl)-4-oxazoleacetic acid (TA-1801A).
    Kaji H; Kume T
    Drug Metab Pharmacokinet; 2005 Jun; 20(3):212-8. PubMed ID: 15988124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
    Al Saabi A; Allorge D; Sauvage FL; Tournel G; Gaulier JM; Marquet P; Picard N
    Drug Metab Dispos; 2013 Mar; 41(3):568-74. PubMed ID: 23230132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.